Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin (pin regimen)in patients with urothelial cancer who have received prior cisplatin-based therapy

被引：0
|
作者：
不详
机构：
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2005年 / 4卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：139 / 139
页数：1
相关论文
共 50 条
  • [21] Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy
    Galsky, Matthew D.
    Moshier, Erin
    Krege, Susan
    Lin, Chia-Chi
    Hahn, Noah
    Ecke, Thorsten
    Sonpavde, Guru
    Godbold, James
    Oh, William K.
    Bamias, Aristotle
    CANCER, 2013, 119 (16) : 3012 - 3019
  • [22] A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy
    Galsky, Matthew D.
    Hahn, Noah M.
    Rosenberg, Jonathan
    Sonpavde, Guru
    Hutson, Thomas
    Oh, William K.
    Dreicer, Robert
    Vogelzang, Nicholas
    Sternberg, Cora
    Bajorin, Dean F.
    Bellmunt, Joaquim
    LANCET ONCOLOGY, 2011, 12 (03): : 211 - 214
  • [23] Cisplatin-Ifosfamide-Gemcitabine as Salvage Chemotherapy in Ovarian Cancer Patients Pretreated with Platinum Compounds and Paclitaxel
    Polyzos, Aristides
    Tsavaris, Nikolas
    Gogas, Helen
    Lagadas, Antonios
    Polyzos, Kostas
    Giannakopoulos, Kostas
    Felekouras, Evangelos
    Tsigris, Christos
    Karatzas, Theodoros
    Papadopoulos, Othon
    Giannopoulos, Athanasios
    ANTICANCER RESEARCH, 2009, 29 (07) : 2681 - 2686
  • [24] Phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer
    Sculier, J. P.
    Lafitte, J. J.
    Lecomte, J.
    Alexopoulos, C. G.
    Van Cutsem, O.
    Giner, V.
    Efremidis, A.
    Berchier, M. C.
    Collon, T.
    Meert, A. P.
    Scherpereel, A.
    Ninane, V.
    Paesmans, M.
    Berghmans, T.
    ANNALS OF ONCOLOGY, 2007, 18 (06) : 1037 - 1042
  • [25] Venous thromboembolic events in patients with lung cancer treated with cisplatin-based versus carboplatin/nedaplatin-based chemotherapy
    Mitani, Akihisa
    Jo, Taisuke
    Yasunaga, Hideo
    Sakamoto, Yukiyo
    Hasegawa, Wakae
    Urushiyama, Hirokazu
    Yamauchi, Yasuhiro
    Matsui, Hiroki
    Fushimi, Kiyohide
    Nagase, Takahide
    ANTI-CANCER DRUGS, 2018, 29 (06) : 560 - 564
  • [26] Personalized peptide vaccination for cervical cancer patients who have received prior platinum-based chemotherapy
    Kawano, Kouichiro
    Tsuda, Naotake
    Waki, Kayoko
    Matsueda, Satoko
    Hata, Yoshiro
    Ushijima, Kimio
    Itoh, Kyogo
    Yamada, Akira
    Kamura, Toshiharu
    CANCER SCIENCE, 2015, 106 (09) : 1111 - 1117
  • [27] Prognostic model for overall survival in patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy
    Galsky, Matt D.
    Krege, Susanne
    Lin, Chia-Chi
    Hahn, Noah M.
    Ecke, Thorsten
    Moshier, Erin L.
    Sonpavde, Guru
    Godbold, James H.
    Oh, William K.
    Bamias, Aristotelis
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy
    Apolo, Andrea B.
    Ostrovnaya, Irina
    Halabi, Susan
    Iasonos, Alexia
    Philips, George K.
    Rosenberg, Jonathan E.
    Riches, Jamie
    Small, Eric J.
    Milowsky, Matthew I.
    Bajorin, Dean F.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (07): : 499 - 503
  • [29] Irinotecan and nedaplatin as salvage therapy for patients with advanced germ cell tumors following intensive treatment with cisplatin-based combination chemotherapies
    Masatomo Nishikawa
    Hideaki Miyake
    Masato Fujisawa
    International Journal of Clinical Oncology, 2016, 21 : 162 - 167
  • [30] IRINOTECAN AND NEDAPLATIN AS SALVAGE THERAPY FOR PATIENTS WITH ADVANCED GERM CELL TUMOR FOLLOWING INTENSIVE TREATMENT WITH CISPLATIN-BASED COMBINATION CHEMOTHERAPIES
    Nishikawa, Masatomo
    Miyake, Hideaki
    Fujisawa, Masato
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1060 - E1060
12345